Prospect for Application of PARP Inhibitor in Patients with HER2 Negative Breast Cancer
Nan Shao(The First People's Hospital of Changzhou), Ying Lin(The University of Osaka), Yawei Shi(The First Affiliated Hospital, Sun Yat-sen University), Yunjian Zhang(Sun Yat-sen University), Zhen Shan(Shenyang Medical College), Runyi Ye(Sun Yat-sen University), Liang Yu(Sun Yat-sen University), Zhanqiang Zhang(Beijing United Family Hospital)
Cited by 19
Related Papers
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
|Nature Communications|2021|358
Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
|Molecules|2022|182
Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
|Cancer Cell International|2020|136
An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells
|Journal of the American College of Cardiology|2015|126